Cardiovascular Diseases

Premature CVD Linked to Worse Midlife Brain Health

A prospective US cohort study indicated that premature cardiovascular disease (CVD before 60 years) is associated with worse midlife cognition and white matter health, which is not entirely driven by stroke/TIA and even independent of CVD risk factors. The study included 3,146 participants, who were 18-30 years at baseline (1985-86, 57% women, 48% Black) and followed up to 30 years. The mean age was 55.1 years, with 5% having premature CVD. Adjusting for demographics, education, literacy, income, depressive symptoms, physical activity, diet, and APOE, premature CVD was associated with lower cognition in 4 out of 5 domains: global cognition (-0.22), verbal memory (-0.28), processing speed (-0.46), and executive function (-0.38). Premature CVD was associated with greater white matter hyperintensity (total, temporal, and parietal lobes) and higher white matter mean diffusivity (total and temporal lobes) in MRI after adjustment for covariates in a subset of 656 participants. These associations remained significant after adjusting for cardiovascular risk factors and excluding those with stroke/TIA. Premature CVD was also associated with accelerated cognitive decline over 5 years (adjusted odds ratio 3.07). The findings suggest that preventing CVD in early adulthood may delay the onset of cognitive decline and promote brain health. A previous study in the cohort has also linked cardiovascular risk factors in mid-life to cognitive decline. Previous research has linked CVD with an increased risk for brain impairment in older adults. Source: https://n.neurology.org/

hyangiu

Recent Posts

The Science and Skepticism around Seed Oils

A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…

2 days ago

Bedtime Antihypertensive Comparable to Morning Use

A Canadian study of adults with high blood pressure (BP) found no difference in health…

4 days ago

Obicetrapib Effective and Safe in Improving Lipids

Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…

1 week ago

Hyperlipidemias and Inflammation Independently and Synergistically Raise CVD Risk

A UK longitudinal associations study revealed that hyperlipidemias and inflammation independently and together raise the…

2 weeks ago

Ultraprocessed Food Consumption and Early Death

A study shows that eating a lot of highly processed foods is likely causing a…

3 weeks ago

Dose Response of Physical Activity in CVD and Mortality

Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…

3 weeks ago

This website uses cookies.